Search results
Team develops computational approach to redesign antibodies for broader effectiveness against viral...
Medical Xpress· 7 days agoThe team's research—published in the journal Nature—showcases a novel antibody design platform...
Antibody Startup Emerges from Stealth: Cell Surface Bio Set to Transform the $10B Antibody Reagent...
NBC 17 Raleigh· 6 days agoProviding monoclonal antibodies that are extensively validated, recombinantly cloned, and exquisitely specific, CSB is being built to transform the >$10 billion antibody reagent ...
Years After His Death, a Late Scientist’s Work Has Opened the Door for Life-Saving New Cancer...
SciTechDaily· 15 hours agoThe final work of a late scientist from the University of Virginia School of Medicine has paved the...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 6 days agoAntibody Startup Emerges from Stealth: Cell Surface Bio Set to Transform the $10B Antibody Reagent Market PR Newswire PHILADELPHIA, May 9, 2024 Company ...
Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA
Digital Journal· 1 day agoThe session, being offered today, Tuesday May 14, 2023 at 8:30 AM Eastern time and entitled " Development of ...
Absci Corp (ABSI) Q1 2024 Earnings Call Transcript Highlights: Strategic Advancements and ...
GuruFocus.com via Yahoo Finance· 7 hours ago:ABSI) has established valuable partnerships with industry leaders such as Merck and AstraZeneca, which helps leverage their platform and advance drug discovery programs. The company's platform ...
Analyst Report: argenx SE
Morningstar Research via Yahoo Finance· 15 hours agoArgenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in the U.S. in December ...
How antibody levels can predict which children will outgrow their peanut allergy
Medical Xpress· 6 days agoThe research, led by Murdoch Children's Research Institute (MCRI) in Melbourne and published in...
Bolt Bio halves workforce and swaps out CEO, while Tenaya lays off 5th of staff
FierceBiotech· 3 hours agoBolt’s plans were the most dramatic, with around 50% of staff being laid off and the company’s CEO...
Nabla Bio secures $26m in Series A funding round
Pharmaceutical Technology via Yahoo Finance· 5 hours agoThey have long been considered the "holy grail" of protein drug development. Nabla’s generative protein design platform is now making hundreds of these...
